NM_005751.5:c.10664A>T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_005751.5(AKAP9):c.10664A>T(p.Asp3555Val) variant causes a missense change. The variant allele was found at a frequency of 0.00117 in 1,612,836 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP9 | NM_005751.5 | c.10664A>T | p.Asp3555Val | missense_variant | Exon 43 of 50 | ENST00000356239.8 | NP_005742.4 | |
AKAP9 | NM_147185.3 | c.10640A>T | p.Asp3547Val | missense_variant | Exon 43 of 50 | NP_671714.1 | ||
AKAP9 | NM_001379277.1 | c.5309A>T | p.Asp1770Val | missense_variant | Exon 22 of 29 | NP_001366206.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000887 AC: 135AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000944 AC: 237AN: 250928Hom.: 0 AF XY: 0.000892 AC XY: 121AN XY: 135656
GnomAD4 exome AF: 0.00120 AC: 1748AN: 1460512Hom.: 1 Cov.: 30 AF XY: 0.00121 AC XY: 876AN XY: 726676
GnomAD4 genome AF: 0.000886 AC: 135AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000873 AC XY: 65AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:3
- -
Variant summary: AKAP9 c.10664A>T (p.Asp3555Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00094 in 250928 control chromosomes. The observed variant frequency is approximately 283 fold of the estimated maximal expected allele frequency for a pathogenic variant in AKAP9 causing Long QT Syndrome phenotype (3.3e-06), strongly suggesting that the variant is benign. c.10664A>T has been reported in the literature as a VUS in sequencing studies of individuals affected with diseases of cardiovascular/metabolic etiology (example, Neubauer_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Long QT Syndrome. At-least one co-occurrence with another pathogenic variant has been observed at our laboratory (PKP2 c.2489+1G>A), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (likely benign, n=3; VUS, n=1). Based on the evidence outlined above, the variant was classified as likely benign. -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:3
- -
- -
- -
Long QT syndrome Uncertain:1Benign:1
Criteria: BS1, PP3 -
- -
Congenital long QT syndrome Uncertain:1
- -
Long QT syndrome 11 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at